Trials / Completed
CompletedNCT04756661
Uterotonics for Severe Preeclampsia
Carbetocin Versus Combined Oxytocin and Misoprostol for Prevention of Postpartum Hemorrhage in Women With Severe Preeclampsia
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 124 (actual)
- Sponsor
- Assiut University · Academic / Other
- Sex
- Female
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The study compares the effect of Intravenous carbetocin versus combined use of intravenous oxytocin and rectal misoprostol for prevention of postpartum hemorrhage during delivery of women with severe preeclampsia
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Carbetocin | 100 mcg of Carbetocin intravenous injection |
| DRUG | Oxytocin | 10 IU oxytocin IV drip |
| DRUG | Misoprostol | 400 mcg rectal |
Timeline
- Start date
- 2020-01-01
- Primary completion
- 2020-12-31
- Completion
- 2021-02-10
- First posted
- 2021-02-16
- Last updated
- 2021-02-16
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT04756661. Inclusion in this directory is not an endorsement.